Cross-national study of women's use of hormone replacement therapy (HRT) in Europe

International Journal of Fertility and Women's Medicine

Volumn 42, Issue SUPPL. 2, 1997, Pages 365-375

  Schneider, H P G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Hormone replacement therapy; Menopause

Indexed keywords

CULTURAL FACTOR; DECISION MAKING; DRUG DELIVERY SYSTEM; EUROPE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; OUTCOMES RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0031407030     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Oddens BJ, Boulet MJ, Lehert P, et al: Has the climacteric been medicalized? A study on the use of medication for climacteric complaints in four countries. Maturitas 15:171-181, 1992.
2. Samsioe G: Hormone replacement therapy in Europe. Int J Fertil 40(Suppl 3):124-128, 1995.
3. Figueroa-Casas PR, Alfonsin A, Arrighi A, et al: Use of a new transdermal delivery system for estrogen replacement therapy in postmenopausal women. Maturitas 20:139-144, 1995.
4. Gordon SF: Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy. Am J Obstet Gynecol 173(3 Pt 2):998-1004, 1995.
5. Samsioe G: The menopause revisited. Int J Gynecol Obstet 51:1-13, 1995.
6. Bachmann GA: Influence of menopause on sexuality. Int J Fertil 40(Suppl 1):16-22, 1995.
7. Barrett-Connor E: Epidemiology and the menopause: a global overview. Int J Fertil 38(Suppl 1):6-14, 1993.
8. Lindsay R: The menopause and osteoporosis. Obstet Gynecol 87(2 Suppl):16S-19S, Feb 1996.
9. Thiebaud D: Prevention of postmenopausal bone loss. Drags Today 32:63-75, 1996.
10. Andrews WC: Continuous combined estrogen/progestin hormone replacement therapy. Clin Therapeut 17(5):812-826, 1995.
11. Grodstein F, Stampfer M: The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 38(3): 199-210, Nov/Dec 1995.
12. Lip GYH, Beevers G, Zarifis J: Hormone replacement therapy and cardiovascular risk: the cardiovascular physicians' viewpoint. J Intern Med 238: 389-399, 1995.
13. Sullivan JM, Fowlkes LP: The clinical aspects of estrogen and the cardiovascular system. Obstet Gynecol 87(2 Suppl):36S-43S, Feb 1996.
14. Halbreich U, Rojansky N, Palter S, et al: Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37:434-441, 1995.
15. Ottowitz WE III, Halbreich U: Mood and cognitive changes following estrogen replacement therapy in postmenopausal women. CNS Drugs 4:161-167, 1995.
16. Calle EE, Miracle-McMahill HL, Thun MJ, et al: Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 87(7):517-523, Apr 1995.
17. Fillit H: Future therapeutic developments of estrogen use. J Clin Pharmacol 35(Suppl):25S-28S, 1995.
18. Utian WH, Schiff I: NAMS-Gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy. Menopause 1(1):39-48, 1994.
19. Draper J, Roland M: Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis. Br Med J 300:786-788, Mar 1990.
20. Dunne FP, Harris P, Keane HL, et al: Hormone replacement therapy and diabetes mellitus. Clin Endocrinol 44:615-620, 1996.
21. Schneider HPG, Dören M: Traits for long-term acceptance or hormone replacement therapy- results of a representative German survey. Eur Menopause J 3(2 Suppl):94-98, 1996.
22. Hope S, Rees MCP, Radcliffe J: Why do British women start and stop hormone replacement therapy? J Br Menopause Soc 12:16-17, 1995.
23. Ferguson KJ, Hoegh C, Johnson S: Estrogen replacement therapy: a survey of women's knowledge and attitudes. Arch Intern Med 149:133-136, Jan 1989.
24. Dören M, Schneider HPG: The impact of different HRT regimens on compliance. Int J Fertil 41(1):29- 39, 1996.
25. Seto TB, Taira DA, Davis RB, et al: Effect of physician gender on the prescription of estrogen replacement therapy. J Gen Intern Med 11:197-203, 1996.
26. Mattson L-A, Milsom I, Stadberg E: What do women want? Br J Obstet Gynaecol 103(Suppl 13):104-107, May 1996.
27. Jewelewicz R: New developments in topical estrogen therapy. Fertil Steril 67(1):1-16, Jan 1997.
28. Balfour JA, McTavish D: Transdermal estradiol: a review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosis. Drugs Aging 2(6):487-507, 1992.
29. Cano A: Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre. Maturitas 20:90-99, 1995.
30. Eiken P, Kolthoff N: Compliance with long-term oral hormonal replacement therapy. Maturitas 22: 97-103, 1995.
31. Barentsen R, Groeneveld FPMJ, Bareman FP, et al: Women's opinion on withdrawal bleeding with hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol 51:203-207, 1993.
32. Hahn RG, Nachtigall RD, Davies TC: Compliance difficulties with progestin-supplemented estrogen replacement therapy. J Fam Pract 18(3):411-414, 1984.
33. Hahn RG: Compliance considerations with estrogen replacement: withdrawal bleeding and other factors. Am J Obstet Gynecol 161(6 Pt 2):1854-1858, 1989.